Superseded. Newer COA available for this product: view newer COA.

Triple Agonist 20mg — Verification Report

From Orvella Labs · Lot rt3-5k2m7 · Tested June 2026

← Back to Orvella Labs

VialTalk

Verification report

Triple Agonist 20mg

Orvella Labs

Score

106.5

Grade

A++

Superlative

Lot rt3-5k2m7

Tested June 2026

Report ID

13432088

Test

Method

Result

Status

PurityFull credit

HPLC

99.64%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentFull credit

Gravimetric vs label claim · tested weight disclosed and verified

20 mg labeled · 27.28 mg tested

Full credit

EndotoxinFull credit

USP <85> compendial

Screened

Full credit

Heavy metalsFull credit

USP <232>/<233> compendial

Screened

Full credit

SterilityPartial

PCR / DNA microarray

Screened

Partial

Batch conformityPartial

Two-batch average

Assessed

Partial

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →